Navigation Links
About 60 Clinical Studies Regarding Schering-Plough's Oncology Compounds Will be Presented at ASCO
Date:5/30/2008

KENILWORTH, N.J., May 30 /PRNewswire-FirstCall/ -- Schering-Plough Corporation (NYSE: SGP) announced today that about 80 posters, poster discussions, and oral presentations from about 60 clinical studies relating to its growing oncology franchise will be presented at the upcoming 44th Annual Meeting of the American Society of Clinical Oncology (ASCO) in Chicago, May 30 - June 3. Data will be presented on TEMODAR(R) (temozolomide) Capsules, CAELYX(R) (pegylated liposomal doxorubicin hydrochloride), INTRON(R) A (Interferon alfa-2b, recombinant) for Injection and peginterferon alfa-2b, as well as the company's investigational oncology compounds including SCH 727965.

-- TEMODAR(R): Twenty-eight abstracts will be presented, including 10

poster discussions and eight oral presentations.

-- CAELYX(R): Eleven abstracts will be presented, including two poster

discussions and two oral presentations.

-- INTRON(R) A and peginterferon alfa-2b: Data will be featured in more

than 10 abstracts, including five poster discussions and five oral

presentations.

Please see important full U.S. Prescribing Information, and the Medication Guides for INTRON(R) A and peginterferon alfa-2b at http://www.schering-plough.com.

Schering-Plough Corp. has exclusive ex-U.S. marketing rights to CAELYX(R), except in Japan and Israel, through a distribution agreement with ALZA, a wholly owned subsidiary of Johnson & Johnson, New Brunswick, N.J., USA. The product is marketed in the United States under the tradename DOXIL(R) by Ortho Biotech Products, L.P. Full EU Prescribing Information may be accessed at

SOURCE Schering-Plough Corporation
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine technology :

1. The Anatomy of Clinical Trials: Greys Season Finale Leaves Public in the Dark About the Myths and Realities
2. Mayo Clinic Proceedings Contributors Highlight Research Findings About Cardiovascular Benefits Associated With Omega-3 Fatty Acids
3. Second Thoughts about Fluoride, Reports Scientific American
4. Bonnie Blair to Break the Ice About Stress Urinary Incontinence in Milwaukee
5. Use it or Lose it: A New Theory About Preserving Erectile Function After Prostate Surgery
6. Wyeth Initiates INTORACT -- A New Clinical Trial to Examine TORISEL Plus Avastin for First-Line Treatment of Advanced Kidney Cancer
7. Human Genome Sciences Initiates First Clinical Trial of Lead IAP Inhibitor HGS1029 in Advanced Solid Tumors
8. Vion Pharmaceuticals to Present Clinical Data on Cloretazine(R) (VNP40101M) at the ASCO(R) Annual Meeting
9. Nektar to Webcast Presentation of Phase 1 Clinical Results for Lead Small Molecule PEG-Oncolytic Program, NKTR-102 (PEG-irinotecan)
10. AMT Announces Positive Interim Clinical Data on its Lead Product AMT-011
11. Two DOXIL(R) Studies to be Presented at American Society of Clinical Oncology (ASCO) Annual Meeting

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/30/2009)... , WALTHAM, Mass., Nov. 30 /PRNewswire/ -...e global authority on medical technology market in...injectable market declined by almost 5% over 2008 ...a result of the economic crisis. The market will, ... return to the strong pre-recession growth rates o...
(Date:11/30/2009)... , ATLANTA, Nov. 30 Amoena U...ry breast care products, is sponsoring the 4th Ann...he first time, Amoena will honor survivors and the...awarding a cabin for the one with the most inspira..., Amoena wants to hear about young mothers who bra...
(Date:11/30/2009)... , BEIJING, Nov. 30 /PRNewswire-Asia-Fir...in Board: LTUS) ("Lotus" or the "Company") a growi...d licensed national seller of pharmaceutical,produ...ay reported that its,Over-the-Counter Drug divisio...y contracts with more than five hundred drug store...
Breaking Medicine Technology:Facial Injectables Emerge From the Recession 2Facial Injectables Emerge From the Recession 3Amoena and Young Survival Coalition Celebrate Breast Cancer Survivors With Contest and Cruise 2Lotus Pharmaceuticals, Inc. Strengthens Beijing Presence with Direct Sales to Drug Stores 2Lotus Pharmaceuticals, Inc. Strengthens Beijing Presence with Direct Sales to Drug Stores 3Aesthera Announces Installation of 1000th Photopneumatic System in US 47928 1Aesthera Announces Installation of 1000th Photopneumatic System in US 47928 2Weber Shandwick Chosen By National Marrow Donor Program 28R 29 To Head Awareness Campaign 47925 1Weber Shandwick Chosen By National Marrow Donor Program 28R 29 To Head Awareness Campaign 47925 2Weber Shandwick Chosen By National Marrow Donor Program 28R 29 To Head Awareness Campaign 47925 3Youth made Stoves Provide Income Protect the Environment 47922 1Youth made Stoves Provide Income Protect the Environment 47922 2
... Variants Are Associated,With Adult Onset Diabetes...st,comprehensive look at genetic risk factors for ...ing in close collaboration with two,other groups, ...associated with increased risk of diabetes and con...he three groups, published,simultaneously today in...
... new study published today,in the New England Jour...ndustry Relationships") on the extent of doctor an... the need for,profession-wide and public policy re...ticle concludes that the existing,voluntary PhRMA...rica) Code isn,t working., The Prescription Projec...
Other Medicine Technology:Researchers Identify New Genetic Risk Factors for Type 2 Diabetes 2Researchers Identify New Genetic Risk Factors for Type 2 Diabetes 3Researchers Identify New Genetic Risk Factors for Type 2 Diabetes 4Researchers Identify New Genetic Risk Factors for Type 2 Diabetes 5Researchers Identify New Genetic Risk Factors for Type 2 Diabetes 6Researchers Identify New Genetic Risk Factors for Type 2 Diabetes 7Ties Between Physicians and Drug Companies Still Too Strong: the,Prescription Project Offers Solutions to Prevent Conflicts of,Interest 2
(Date:11/30/2009)... , Sponsored by Merck, the unique online a...icipants in their HIV treatment decisions ,, A...- TheBody ( www.thebody.com ), the #1 HIV/AIDS res... online and mobile tool offering HIV/AIDS-infected...heir medical data. The tool, created with sponsors...
(Date:11/30/2009)... , Study Uses Tent To Si...EW YORK, Nov. 30 Distan...gen levels are known to improve their performance ... heart failure patients, who suffer from fatigue, ... tent-like, high-altitude simulator? ,, That is...
(Date:11/30/2009)... , NEW YORK, Nov. 30 O...tates who are living with HIV/AIDS, nearly half ar...on rates in Washington, D.C. have surpassed the th... Black women account for more than 90 percent of a...apitol. On Tuesday, December 1 at 6:00 p.m.*, Worl...
(Date:11/30/2009)...ere is a tiny period of time between the registrat...nd our conscious recognition of it ― between...e it as an apple. Our minds lag behind our eyes, b...ions to the world around us? , Some estimates ...hers say 500 milliseconds. A new study by Tel Aviv...
(Date:11/30/2009)... Keynote speaker & Author... , Corpus Christi, TX (Vo...Autism Conference is set to be held in Corpus Chr...ecember 5, 2009 at the American Bank Center., , ,...is expected to make a nearly $300,000 economic imp...
Breaking Medicine News(10 mins):Health News:TheBody.com Launches My Health Tracker, Enabling HIV-Positive Patients to Track Lab Results, Medications and Supplements 2Health News:Can Exposure to Low Oxygen Levels Benefit Heart Failure Patients? 2Health News:Can Exposure to Low Oxygen Levels Benefit Heart Failure Patients? 3Health News:Can Exposure to Low Oxygen Levels Benefit Heart Failure Patients? 4Health News:BET Networks Joins the International Call to Stop the Spread of HIV on World Aids Day Tuesday, December 1 with an Annual Special Episode of '106 & PARK' and on the Ground Initiatives Through BET's Award Winning Public Affairs Campaign Rap-It-Up 2Health News:BET Networks Joins the International Call to Stop the Spread of HIV on World Aids Day Tuesday, December 1 with an Annual Special Episode of '106 & PARK' and on the Ground Initiatives Through BET's Award Winning Public Affairs Campaign Rap-It-Up 3Health News:Now you see it, now you know you see it 2Health News:18th Annual Texas Autism Conference Returns To Corpus Christi, Makes Nearly $300,000 Economic Impact 2
...Partner, Paladin, Enters Into Co- Pr...C, Feb. 1 /PRNewswire-FirstCall/ - Labopharm Inc. ...anadian licensing and distribution,partner for its...ada Inc. The agreement will double the number of p...
...y joy and goodwill that,epitomise Christmas and th...tions, letdowns, tension and, not least, drinking ... of the year for someone with alcohol,issues: offi... the merriment of Christmas and the New Year masks...
...ir Employee Health Benefit Plans Stack Up, PARSIP...ource executives grappling with ways to keep their...t effective found out how their plans,compare to o... Benefit Sources & Solutions in Bound Brook,presen...
...creased chances by 85%, study finds , , T...f sugar-sweetened soft drinks and fructose is stro..., a new study says. , Gout, caused by excess uric ...ates over the past few decades. , In this study, p...
...el drug romiplostim (Nplate) show that it signific...ronic immune thrombocytopenic purpura (ITP), a hem...ding. An international research team reports Phas... the February 2 issue of The Lancet. , Many ITP ...
...Office of Management and Budget evaluates research...ther federal agencies using the Program Assessment...agencies about many aspects of their programs, inc...effective, or somewhere in between. An "ineffecti...
Other Medicine News:Health News:Canadian Marketing and Sales Effort for Labopharm's Once-Daily Tramadol Product to Expand Significantly 2Health News:Canadian Marketing and Sales Effort for Labopharm's Once-Daily Tramadol Product to Expand Significantly 3Health News:A Festive White Knuckle Ride? 2Health News:Key to Attracting and Retaining Quality Employees: Benefits 2Health News:Key to Attracting and Retaining Quality Employees: Benefits 3Health News:Sugary Soft Drinks Boost Gout Risk in Men 2Health News:Drug-based on MGH discovery may significantly improve treatment of dangerous blood disorder 2Health News:Changes needed in how federal government evaluates efficiency of research at EPA, other agencies 2
Kelman-McPherson Angled Suturing-Corneal Forceps
Lieberman Suturing Forceps
Watzke Sleeve Spreading Forceps
Castroviejo Suture Forceps
Medicine Products: